Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi

Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi

OBJECTIVE: To estimate the impact of cotrimoxazole prophylaxis on the survival of human immunodeficiency virus (HIV)-positive tuberculosis (TB) patients. METHODS: A cohort study with a historical comparison group was conducted. End-of-treatment outcomes and 18-month survival were compared between TB...

Full description

Bibliographic Details
Main Authors:	Mwaungulu Frank B.D., Floyd Sian, Crampin Amelia C., Kasimba Simplex, Malema Simon, Kanyongoloka Huxley, Harries Anthony D., Glynn Judith R., Fine Paul E.M.
Format:	Article
Language:	English
Published:	The World Health Organization 2004-01-01
Series:	Bulletin of the World Health Organization
Subjects:	Trimethoprim-sulfamethoxazole combination/pharmacology Tuberculosis/mortality Tuberculosis/drug therapy AIDS-related opportunistic infections/drug therapy HIV infections Treatment outcome Survival analysis Cohort studies Malawi
Online Access:	http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862004000500009

Similar Items

Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection
by: Gill Christopher J., et al.
Published: (2004-01-01)

Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan
by: Rasmussen Zeba A., et al.
Published: (2005-01-01)

Mycobacterium tuberculosis Beijing Genotype, Northern Malawi
by: Judith R. Glynn, et al.
Published: (2005-01-01)

Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011–2020
by: Chong Kei Lao, et al.
Published: (2022-10-01)

A Rare Cause of Drug-Induced Pancytopenia: Trimethoprim–Sulfamethoxazole-Induced Pancytopenia
by: Khalid Sawalha, et al.
Published: (2021-06-01)

Sulfamethoxazole stone in a patient with extensive history of urolithiasis and recurrent urinary tract infections
by: Abbie M. Chase, et al.
Published: (2021-11-01)

Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: An interplay of unbalanced immune regulatory mechanisms
by: Wikrom Karnsakul, et al.
Published: (2006-04-01)

Operational research in malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV
by: Schouten Erik J, et al.
Published: (2011-07-01)

Appropriate antibiotic therapy is a predictor of outcome in patients with Stenotrophomonas maltophilia blood stream infection in the intensive care unit
by: Jiun-Ji Lai, et al.
Published: (2023-06-01)

Clinical Characteristics, Diagnosis, and Management of Aseptic Meningitis Induced by Trimethoprim-Sulfamethoxazole
by: Fan Z, et al.
Published: (2023-09-01)

Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole
by: G. Kouklakis;, et al.
Published: (2007-01-01)

Trimethoprim-Sulfamethoxazole Resistance and Fosfomycin Susceptibility Rates in Uncomplicated Urinary Tract Infections: Time to Change the Antimicrobial Preferences
by: Ozlem Guneysel, et al.
Published: (2016-01-01)

Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates
by: Branko Jovčić, et al.
Published: (2017-12-01)

Efficacy of initial caspofungin plus trimethoprim/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection
by: Hui Qi, et al.
Published: (2023-06-01)

Oral antibiotic prophylaxis for infection in patients with vascular anomalies receiving sirolimus treatment: a multicenter retrospective study
by: Tong Qiu, et al.
Published: (2023-05-01)

Combination of clindamycin and primaquine for Pneumocystis pneumonia in renal transplant recipients
by: Mohammed Shoeb Ahmed Khan, et al.
Published: (2019-01-01)

Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate
by: Mohammed Alsuhaibani, et al.
Published: (2021-01-01)

Stenotrophomonas maltophilia in Lower Respiratory Tract Infections
by: Kiran Chawla, et al.
Published: (2014-12-01)

Evaluation of Reported Adverse Drug Reactions in Antibiotic Usage: A Retrospective Study From a Tertiary Care Hospital, Malaysia
by: Ann L. Arulappen, et al.
Published: (2018-08-01)

Serum Peak Sulfamethoxazole Concentrations Demonstrate Difficulty in Achieving a Target Range: A Retrospective Cohort Study
by: Bao D. Dao, PharmD, et al.
Published: (2014-12-01)

Sulfamethoxazole-induced sulfamethoxazole urolithiasis: a case report
by: Megan M. Roedel, et al.
Published: (2021-09-01)

Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area
by: JA Guerra-Assunção, et al.
Published: (2015-03-01)

An unexpected cause of hyponatremia in a cancer patient: Trimethoprim-sulfamethoxazole
by: Dilsa Mizrak, et al.
Published: (2016-04-01)

Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage
by: Boerma J Ties, et al.
Published: (2006-01-01)

The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: a retrospective study
by: Berhe Tesfaye, et al.
Published: (2012-04-01)

Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction
by: Amanda Rocha Firmino Pereira, et al.
Published: (2019-11-01)

Biofilm formation in trimethoprim/sulfamethoxazole-susceptible and trimethoprim/sulfamethoxazole-resistant uropathogenic Escherichia coli
by: Nitis Smanthong, et al.
Published: (2015-06-01)

Evaluation of Hiv Infection And Tuberculosis Concomitance
by: Behice KURTARAN, et al.
Published: (2015-12-01)

Antibiotic prophylaxis in immunosuppressed patients – Missed opportunities from trimethoprim-sulfamethoxazole allergy label
by: Wei-I Lee, MBBS, FRACP, et al.
Published: (2024-01-01)

Drug-induced Hypersensitivity Syndrome Associated with a Marked Increase in Anti-paramyxovirus Antibody Titers in a Scleroderma Patient
by: Taio Naniwa, et al.
Published: (2007-01-01)

Aseptic meningitis, hepatitis and cholestasis induced by trimethoprim/sulfamethoxazole: a case report
by: J. A. A. van Asperdt, et al.
Published: (2021-08-01)

Life-Threatening Hyperkalemia following Low-Dose Trimethoprim-Sulfamethoxazole: A Case Report
by: Hikaru Katagiri, et al.
Published: (2023-05-01)

Psychosis resulting from trimethoprim-sulfamethoxazole treatment for preseptal cellulitis
by: Kashif M Iqbal, et al.
Published: (2022-01-01)

by: Fernanda Sampaio Cavalcante, et al.
Published: (2013-01-01)

A prospective randomized trial of azithromycin versus trimethoprim/sulfamethoxazole in treatment of toxoplasmic retinochoroiditis
by: Alireza Lashay, et al.
Published: (2017-06-01)

Rapid and Accurate Detection of <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Strains Susceptible/Resistant to Cotrimoxazole through Evaluation of Cell Elongation
by: Isidoro López, et al.
Published: (2021-06-01)

Efficacy of Trimethoprim–Sulfamethoxazole in Combination with an Echinocandin as a First-Line Treatment Option for Pneumocystis Pneumonia: A Systematic Review and Meta-Analysis
by: Hideo Kato, et al.
Published: (2022-05-01)

Cross-resistance between trimethoprim-sulfamethoxazole and other common antibiotics among urinary isolates of escherichia coli - an in-vitro retrospective analysis
by: B V Navaneeth, et al.
Published: (2001-01-01)

Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study
by: Ruo-Yang Chen, et al.
Published: (2022-12-01)

Severe skin and subcutaneous pythiosis in China: Metagenomic identification and characterization of Pythium insidiosum
by: Haiyan Zhang, et al.
Published: (2022-09-01)